Polycyclic aromatic hydrocarbons (PAHs) are widespread environmental contaminants that interact in a complex manner with both the aryl hydrocarbon receptor (AhR) and estrogen receptors (ER). Their potential endocrine-disrupting activities may depend on both inhibitory AhR-ER cross-talk and on AhR-dependent metabolic production of estrogenic PAH metabolites. Here, we analyzed the impact of AhR on estrogen-like effects of PAHs, such as benzo [a]pyrene (BaP), in particular, on control of cell cycle progression/cell proliferation. Using AhR knockout variant of estrogen-sensitive human breast cancer MCF-7 cells (MCF-7 AhR KO cells), we observed that the AhR-dependent control of cytochrome P450 family 1 (CYP1) expression played a major role in formation of estrogenic BaP metabolites, most notably 3-OH-BaP, which contributed to the ER-dependent induction of cell cycle progression/cell proliferation. Both BaP metabolism and the BaPinduced S-phase transition/cell proliferation were inhibited in MCF-7 AhR KO cells, whereas these cells remained sensitive towards both endogenous estrogen 17b-estradiol or hydroxylated BaP metabolites. BaP was found to increase the activity of ER-dependent luciferase reporter gene in wild-type MCF-7 cells; however, unlike its hydroxylated metabolite, BaP failed to stimulate luciferase activity in MCF- and CYP1B1 enzymes partly restored both BaP metabolism and its effects on cell proliferation. Taken together, our data suggest that the AhR-dependent metabolism of PAHs contributes significantly to the impact of PAHs on cell proliferation in estrogen-sensitive cells.
Polycyclic aromatic hydrocarbons (PAHs) are a large group of organic pollutants, widely distributed in the environment in form of complex mixtures, which are generally produced in incomplete combustion processes (Boströ m et al., 2002) . The toxic modes of action of PAHs include both their genotoxicity, linked with production of mutagenic metabolites forming covalent DNA adducts (Baird et al., 2005) , and a range of less defined nongenotoxic effects contributing to their toxicity, based, e.g., on the interactions of PAHs with specific intracellular receptors, such as the aryl hydrocarbon receptor (AhR) ; Vondr a cek et al., 2017), nuclear receptors or interference with other intracellular signaling pathways (Hardonnière et al., 2017; Zhang et al., 2016) . During recent years, an increasing attention has been paid to the impact of PAHs or their mixtures on receptors for steroid hormones, such as androgen receptor and, in particular, estrogen receptors (ER) (Zhang et al., 2016) .
Although a number of studies have indicated that PAHs may interfere with estrogenic signaling, the exact mechanisms of their action are still not fully clear. Several early studies have suggested that PAHs acting as relatively strong AhR ligands, such as benzo [k] fluoranthene, exert anti-estrogenic effects (Arcaro et al., 1999; Chaloupka et al., 1992) . This has been attributed to the PAH-induced activation of the AhR and the subsequent inhibition of estrogenic signaling via inhibitory crosstalk between the AhR and ERa. The mechanisms underlying this cross-talk may include, e.g., interference of the AhR-controlled enzymes with endogenous estrogen metabolism, the AhRinduced ERa degradation, competition of the two receptors for common transcriptional co-activators, or, a direct inhibition of the ER-dependent transcription via the AhR binding to inhibitory dioxin responsive elements within promoter regions of ERresponsive genes (Matthews and Gustafsson, 2006; Safe and Wormke, 2003; Shanle and Xu, 2011) . In contrast to the proposed anti-estrogenic action of PAHs, further studies have revealed that a number of PAHs, including, e.g., 3-methylcholanthrene, BaP, or benz [a] anthracene (BaA), exhibit direct or indirect estrogen-like effects in a variety of both in vitro and in vivo assays Gozgit et al., 2004; Kummer et al., 2008; Liu et al., 2006; Pl ı skov a et al., 2005b; Shipley and Waxman, 2006; Swedenborg et al., 2008; Vondr a cek et al., 2002) . A recent study screening the Tox21 10,000 compound library also identified PAHs as ERa agonists (Huang et al., 2015) . The estrogenic action of some AhR ligands, including PAHs, have been attributed to their direct binding to ERa . However, others have reported that metabolites of some environmentally abundant PAHs, such as chrysene or BaP, and not the parent PAHs themselves, play a major role in ERa transactivation (Charles et al., 2000; Fertuck et al., 2001b; van Lipzig et al., 2005) . Therefore, PAH metabolism would play a major role in determination of effects of PAHs on endocrine system, as it may act in a cell-specific manner or produce PAH metabolites interacting with specific ER subtypes (Sievers et al., 2013; Swedenborg et al., 2008) . However, most of the previous studies investigating the role of metabolism in anti-estrogenic or estrogenic action of PAHs have relied on the use of chemical inhibitors of cytochrome P450 family 1 (CYP1) activity or AhR antagonists, such as a-naphthoflavone or 3 0 , 4 0 -dimethoxyflavone, which may alter both the AhR activity and the action of estrogens (Charles et al., 2000; Fertuck et al., 2001b; Lam et al., 2018) . The complex nature of the interactions among ERa, AhR, and its transcriptional partner AhR nuclear translocator (ARNT) Beischlag and Perdew, 2005; Labrecque et al., 2012; Ruegg et al., 2008; Wihlen et al., 2009) (Ahmed et al., 2014) . MCF-7 cell line represents the most frequently used model for studying the effects of PAHs on estrogen signaling, with a sufficient metabolic capacity to generate large quantities of PAH metabolites. This cell line has been successfully used to evaluate the impact of PAHs on ERa, using both reporter gene assays and endogenous responses of cells, such as regulation of ER-dependent cell cycle and proliferation, as relevant endpoints Fertuck et al., 2001b; Pl ı skov a et al., 2005b; Vondr a cek et al., 2002) . BaP-resistant MCF-7 cells, which lost AhR responsiveness, have been also previously shown to be a useful tool to study the impact of environmental pollutants, such as dioxin, on ER activity (Moore et al., 1994) . Therefore, in the present study, we have employed the AhR knockout variant of MCF-7 cells, created via targeted AhR disruption (Ahmed et al., 2014) , in order to address the role of AhR in the effects of PAHs previously identified as estrogenic compounds on ER activation and/or on stimulation of ER-dependent cell cycle progression/cell proliferation. We primarily focused on discrimination between the effects of parent PAHs and their metabolites. Our present results suggest that, while PAHs have some limited effects on ER proliferative signaling, the AhRdependent metabolism of PAHs via CYP1 enzymes (leading to production of estrogen-like active PAH metabolites) contributes significantly to their estrogen-like effects on cell proliferation.
MATERIALS AND METHODS
Chemicals. BaP and BaA were purchased from Fluka (Buchs, Switzerland) and Sigma-Aldrich (Prague, Czech Republic), respectively. 3-Methylcholanthrene (3MC) was from Santa Cruz Biotechnology (Santa Clara, California). BaP metabolite standards [BaP-tetrol I-1], BaP-r-7, t-8, t-9, t-10-tetrahydrotetrol(6) [BaP-tetrol I-2], [BaP-tetrol II-1], , BaP-trans-9, 10-dihydrodiol [BaP-9, 10-DHD], , BaP-3, 6-dione, BaP-1,6-dione, BaP-6,12-dione, 1-OH-BaP, 3-OH-BaP and 9-OH-BaP) were all obtained from the National Cancer Institute's Chemical Carcinogen Standard Reference Repository (Midwest Research Institute, Kansas City, Missouri). The identities and purities of all standards were established by highperformance liquid chromatography (HPLC). Ethyl acetate (p.a. ACS), methanol (p.a. ACS), and methanol (HPLC gradient grade) were all purchased from Merck (Darmstadt, Germany). 17b-Estradiol (E2; Sigma-Aldrich) was used as a positive control for all estrogenicity assays at the indicated concentrations. 2, 3, 7, (TCDD), purchased from Cambridge Isotope Laboratories (Andover, Massachusetts), was used as a model AhR agonist. 7a, 4, 5, 5, sulfinyl]nonyl]estra-1,3,5(10)-triene-3,17-diol (ICI182,780; Tocris Bioscience, Bristol, UK), was used as ER antagonist. All test compounds were dissolved in DMSO (Merck) and the final concentration of the solvent in the experimental medium did not exceed 0.2% (v/v). All other reagents were obtained from Sigma-Aldrich, unless stated otherwise.
Cell lines and cultivation conditions. Human breast cancer MCF-7 wild-type (MCF-7 AhR wt) cells, obtained from American Type Culture Collection (ATCC, Rockville, Maryland) and MCF-7 AhR knockout cells (MCF-7 AhR KO ), which were generated as described previously (Ahmed et al., 2014) were cultivated in Dulbecco's modified Eagle's medium/nutrient mixture F-12 Ham (DMEM/F12, Gibco, Thermo Fisher Scientific, Waltham, Massachusetts) supplemented with 1% penicillin-streptomycin and 5% or 10% fetal bovine serum (FBS; v/v), respectively (Thermo Fisher Scientific). The cells were maintained at 37 C in 5% CO 2 and 95% humidity, and they were subcultured every 2-3 days, or, when they reached 80% confluency. MCF-7 BOS cells (Soto et al., 1995) , which were kindly provided by A. M. Soto (Tufts University, Boston, Massachusetts), were cultivated as the other MCF-7 variants. T47D human breast carcinoma cells, which were used for cloning of CYP1A1 and CYP1B1 expression vectors, were purchased from ATCC and cultured in DMEM/F12 supplemented with 10% FBS (v/v) and 1% penicillinstreptomycin. The cells were maintained at 37 C and 5% CO 2 and subcultured every 2-3 days, or, when they reached 80% confluency. The T47D.Luc cells, stably transfected with pEREtataLuc reporter construct (Legler et al., 1999) Reporter gene assay. Cells were treated with DMSO (negative control), E2 (positive control), BaA, BaP, 3MC or 3-OH-BaP 24 h after transfection in experimental medium and then incubated for indicated time. Following the treatment, medium was aspirated, cells were washed with phosphate-buffered saline (PBS) and lysed with passive lysis buffer (Promega). Luciferase activity was then measured using the Dual-Luciferase Reporter Assay (Promega), according to the manufacturer's instructions, on LM-01T luminometer (Immunotech, Prague, Czech Republic).
The firefly luciferase activity in each treatment was normalized to the corresponding Renilla luciferase activity and expressed relative to maximum E2-induced response. Determination of estrogenic activity of PAHs and hydroxylated BaP metabolites in T47D.Luc cells is described in detail in the legend to Supplementary Figure 4 .
Cell cycle analysis. Cells were grown in experimental medium and then synchronized using phenol red-free DMEM/F12, supplemented with 5% dextran/charcoal-treated FBS (experimental medium) for 48 h, as indicated above. Cells were then treated with indicated compounds for 24 h, using DMSO and E2 as negative and positive controls, respectively. In experiments with ICI182,780, this was added 1 h before addition of test compounds. Following the treatment, cells were harvested by trypsinization, washed twice in PBS, and fixed in 70% ethanol. DNA was stained (37 C; 30 min) with Vindelov's solution (10 mM Tris buffer, pH 8; 0.7 mg/ml RNAse; 50 lg/ml propidium iodide; 0.1% Triton-X100). The DNA content was analyzed by flow cytometer (FACSCalibur, Becton Dickinson, San Jose, California; using 488 nm argon ion laser for excitation). A total of 15,000 events were acquired per each sample and the percentage of cells in the individual cell cycle phases was analyzed using ModFit 3.0 software (Verity Software House, Topsham, California). Single cells were identified and gated by pulse-code processing of the area and the width of the signal. Cell debris was excluded by using the forward scatter threshold.
WST-1 assay. MCF-7 wt and MCF-7 AhR KO cells were seeded at density of 3,000 cells per well in 100 ll of experimental medium in 96-well cell culture plates. The cells were allowed to attach for 24 h and then synchronized for 48 h. Test compounds, DMSO (negative control) and E2 (positive control) were then added in 100 ll of experimental medium supplemented with 5% dextran/ charcoal-treated FBS. Five days later, 10 ll of cell proliferation reagent WST-1 (Roche Diagnostics, Mannheim, Germany) were added into each well and cells were incubated with WST-1 in cultivation condition for another 3 h in case of MCF-7 wt cells or 24 h in case of MCF-7 AhR KO cells, as these cells exhibited a slower rate of metabolism. Following the incubation, the absorbance of WST-1 product was measured with a microplate spectrophotometer at 450 nm. In order to confirm that WST-1 data
corresponded with actual cell numbers of MCF-7 AhR KO cells, we further employed CyQUANT Cell Proliferation Assay (Thermo Fisher Scientific) using CyQUANT V R GR dye, which detects cellular nucleic acids. Cells at the end of incubation period were stained according to the manufacturer's instructions and fluorescence measurements were made using a microplate reader with excitation at 485 nm and emission detection at 530 nm.
Measurement of 7-ethoxyresorufin-O-deethylase (EROD) activity. EROD activity in untreated or TCDD-treated MCF-7 wt and MCF-7 AhR KO cells was measured as described previously (Kab atkov a et al., 2015) . Briefly, at the end of incubation period, cells were washed twice with cold PBS, lysed and resorufin production was then measured in 96-well plates. Each well contained 20 ll of cell lysate, 2 mM 3, 3 0 -methylene-bis(4-hydroxycoumarin) (Sigma-Aldrich) in 50 ll of Tris-sucrose buffer (pH 8.0), and 25 ll of 20 lM 7-ethoxyresorufin (Sigma-Aldrich). The plates were pre-incubated for 20 min at 37 C, and 25 ll of 1 mM NADPH solution were added per well, in order to start the reaction. Plates were then incubated for 1 h at 37 C and resorufin production was then measured in Fluostar Galaxy (BMG Labtech GmbH, Ortenberg, Germany) with an excitation at 530 nm and emission detection at 590 nm. Protein concentrations were estimated using the bicinchoninic acid method. The levels of EROD activity were expressed relative to maximum EROD induction induced by 10 nM TCDD in MCF-7 wt cells.
Real-time quantitative RT-PCR (qRT-PCR) analysis. MCF-7 wt and MCF-7 AhR
KO cells were grown in 35 mm diameter cell culture dishes in experimental medium in presence of 10 lM BaP. Cells were collected at indicated time points, washed twice with cold PBS and lysed with cell lysis buffer. In experiments employing transient transfection of hCYP1A1 and hCYP1B1 expression vectors in MCF-7 AhR KO cells, the transfections were carried out 24 h before the collection of cells. Total RNA was isolated from cells using the NucleoSpin V R RNA II purification kit (MachereyNagel, Dü ren, Germany). The amplification of the samples was carried out with Superscript III Platinum One-Step qRT-PCR kit (Invitrogen, Carlsbad, California) . Primers and the respective probes were provided by Generi Biotech (Hradec Kr alov e, Czech Republic) or Roche Diagnostics (Mannheim, Germany). qRT-PCR reactions were performed using RotorGene 6000 (Corbett Life Science, Qiagen) thermocycler. The sequences of primers and probes for human CYP1A1, CYP1B1, and TBP reference gene, as well as qRT-PCR conditions, have all been reported previously (Kab atkov a et al., 2015).
Analysis of BaP metabolites. MCF-7 wt and MCF-7 AhR
KO cells were grown in 60 mm cell culture dishes in experimental medium. Following the incubation of cells with BaP, cells were washed twice with cold PBS, scraped into Eppendorf tubes, centrifuged and the cell pellets were stored at À80 C until further analysis.
In the experiments employing transient transfection of hCYP1A1 and hCYP1B1 expression vectors into MCF-7 AhR KO cells, the transfections were carried out 24 h before the onset of BaP treatment. Determination of BaP metabolites was then performed as described previously (Kab atkov a et al., 2015) . Briefly, cell pellets were extracted twice with 700 ll of ethyl acetate, combined extracts were dried under a stream of nitrogen, redissolved in 50 ll of methanol and aliquot of 10 ml was injected into the HPLC column. The Agilent 1200 chromatographic system (Agilent Technologies, Santa Clara, California) was used for the LC-MS/MS analyses, using the conditions described previously (Kab atkov a et al., 2015). A triple quadrupole mass spectrometer Agilent 6410 Triple Quad LC/MS (Agilent Technologies) with an atmospheric pressure chemical ionization was used for detection of the analytes. The levels of BaP metabolites were normalized to protein concentrations estimated with the bicinchoninic acid method.
Western blotting. Whole cell lysates were prepared by washing the cells twice in PBS and then harvested in 90 ml cell lysis buffer (1% SDS, 10% glycerol, 100 mM Tris pH 7.4, 1 mM NaF, 1 mM Na 3 VO 4 , 1 mM PMSF). Cell lysates were sonicated and protein concentration was determined by using the bicinchoninic acid method. Samples were mixed with SDS loading buffer (240 mM Tris-HCl pH 6.8, 6% SDS, 0.02% bromophenol blue, 30% glycerol, 3% b-mercaptoethanol) and boiled for 10 min. Equal amounts (20-30 lg) of total protein were subjected to SDS-PAGE using 10% polyacrylamide gels and transferred to polyvinylidene fluoride membranes (PVDF; GE Healthcare, Little Chalfont, UK) in a buffer containing 192 mM glycine, 25 mM Tris, and 10% methanol. The membranes were blocked for 1 h in 5% powdered nonfat milk in wash buffer (0.05% Tween-20 in 20 mM Tris; pH 7.4; 100 mM NaCl Statistical analyses. The data are presented the means 6 SD of at least three independent experiments. Differences between the groups were calculated using one-way ANOVA. With all statistical analyses, an associated probability (p-value) of <5% was considered significant.
RESULTS

Inducibility of Both Expression and Activity of CYP1A1/1B1 Is Severely Limited in MCF-7 AhR KO Cells
The loss of AhR expression in MCF-7 cells has been shown to significantly reduce basal levels of CYP1B1 and CYP1A1, as well as to prevent inducible expression of these principle enzymes involved in detoxification and metabolic activation of BaP or related PAHs (Ahmed et al., 2014) . In order to verify that the cells used in this study exhibit this phenotype, we first determined levels of AhR protein, inducibility of EROD activity and induction of CYP1A1/1B1 mRNAs in MCF-7 AhR KO cells, and compared them with MCF-7 AhR wt cells. As shown in Figure 1 , no AhR protein was detected in MCF-7 AhR KO cells by Western blotting ( Figure 1A ) and TCDD failed to stimulate any detectable EROD activity in AhR knockout cells ( Figure 1B) . BaP, which was used as a model PAH in our study, induced both CYP1A1 and CYP1B1 mRNAs in MCF-7 AhR wt cells, in a time-dependent manner; however, no induction of either enzyme was observed in MCF-7 AhR KO cells ( Figure 1C wild-type cells. We incubated both cell lines with 10 lM BaP and collected them for analyses of BaP metabolites after 3, 6, and 24 h of exposure. As shown in Figure 2A , loss of AhR, which was associated with the lack of CYP1A1/1B1 expression/activity, severely limited formation of major BaP metabolites in MCF-7 AhR KO cells. This was particularly evident at 24 h, where maximum levels of signature BaP metabolites, such as BaP-tetrols or BaP-DHDs, were several orders of magnitude higher in wildtype cells. Importantly, high levels of hydroxylated BaP metabolites, such as 1-, 3-and 9-OH-BaP, which have been shown to activate ER (Charles et al., 2000; Fertuck et al., 2001b; van Lipzig et al., 2005) , were only detected in MCF-7 AhR wt cells. Similar trends were observed also when we analyzed formation of BaP metabolites in MCF-7 cells treated with lower BaP concentrations (data not shown). In contrast, formation of BaP quinones, which are formed via radical cation pathway (Xue and Warshawsky, 2005) , was less affected. Levels of BaP-6, 12-dione even slightly increased in knockout cells, thus indicating that some non-AhR-inducible enzymatic activity, perhaps masked by CYP1 enzymes in wild type cells, could be responsible for production of this BaP metabolite. Representative LC-MS/MS chromatograms showing profiles of major BaP metabolites in MCF-7 AhR KO and MCF-7 AhR wt cells are shown in Figure 2B . As shown in Supplementary Figure 1 , E2 stimulated G 1 -to-Sphase transition of MCF-7 AhR KO cells, in a similar manner as in parental cell line or in MCF-7-BOS variant used for E-screen assay (Soto et al., 1995) . MCF-7 AhR KO cells exhibited a better response to synchronization in dextran/charcoal-treated FBS, which might be the reason for lower percentage of S-phase found in control cells. Nevertheless, both cell lines exhibited a similar relative increase of percentage of cells in S-phase, which indicated that their proliferative responses to E2 remained comparable. In addition, we observed that E2 induced, in a dosedependent manner, cell proliferation in both MCF-7 AhR wt and MCF-7 AhR KO cells, as determined by WST-1 assay (Supplementary Figure 2) , although reduction of WST-1 dye proceeded at a slower rate in MCF-7 AhR KO cells (data not shown). These results confirmed that the loss of AhR did not block estrogen-like responses in MCF-7 cells. Both BaA and BaP stimulated progression of cells into Sphase of cell cycle, and cell proliferation, in MCF-7 AhR wt cells (Figs. 3A and 3B ). In contrast, we observed that in MCF-7 AhR KO cells, induction of cell cycle progression by PAHs was significantly impaired ( Figure 3A) . Although a minor increase was observed for BaA, this was still lower than the effect of E2 in synchronized in experimental medium (phenol red-free DMEM/F12, supplemented with 5% dextran/charcoal-treated FBS) for 48 h and then exposed to DMSO (0.1%; negative control), E2 (100 pM; positive control), BaA (10 lM), or BaP (10, 25, and 50 lM) for 24 h. Percentage of cells in S-phase was determined using flow cytometry as described in Materials and Methods. The results shown here represent means 6 SD of three independent experiments. Symbol "*" denotes significant difference (p < .05), as compared with DMSO-treated cells. Symbol "**" denotes significant difference (p < .01), as compared with DMSO-treated cells. Symbol "#" denotes significant difference (p < .05), as compared to E2-treated cells. Symbol "##" denotes significant difference (p < .01), as compared to E2-treated cells. B, MCF-7 AhR wt and MCF-7 AhR KO cells were synchronized in experimental medium for 48 h and then exposed to DMSO (0.1%; negative control), E2 (100 pM; positive control), BaA (10 lM), or BaP (10 lM) for 120 h. Cell proliferation was estimated using WST-1 assay as described in Materials and Methods. The results of absorbance detection were expressed relative to negative control (DMSO) and they represent means 6 SD of three independent experiments. Symbol "*" denotes significant difference (p < .05), as compared to DMSO-treated cells. C, MCF-7 AhR wt and MCF-7 AhR KO cells were cultured and treated as in (B). Cells were exposed to DMSO (0.1%; negative control), E2 (100 pM; positive control), or indicated concentrations of 3MC for 120 h. Cell proliferation was estimated using WST-1 assay as described in Materials and Methods. The results of absorbance detection were expressed relative to negative control (DMSO) and they represent means 6 SD of three independent experiments. Symbol "*" denotes significant difference (p < .05), as compared with DMSO-treated cells. Symbol "**" denotes significant difference (p < .01), as compared with DMSO-treated cells. Figure 3B ).
Since we observed that the WST-1 reduction rate was slower in MCF-7 AhR KO cells, we next verified our findings by using
CyQUANT assay, which determines the levels of nucleic acids with a fluorescent dye. We found that although E2 (in a dosedependent manner) significantly increased fluorescence in MCF-7 AhR KO cells, the proliferative effects of both BaA and BaP were inhibited in cells lacking the AhR protein ( Supplementary  Figure 3) . Finally, we used 3MC, as a model PAH which has been shown to directly activate ERa, to stimulate ERa-dependent transcription, and to increase uterine wet weight in a mouse assay in vivo Liu et al., 2006) . As shown in Figure 3C , 3MC stimulated cell proliferation in a dosedependent manner (up to 50 lM concentration) in MCF- Since the results of proliferation assays indicated that a majority of estrogenic effects of PAHs depended on their CYP1-mediated metabolism, we next investigated their effects on ER transcriptional activity, using ER-dependent reporter gene. As shown in Figure 4A , PAHs increased, in a dose dependent manner, luciferase activity in MCF-7 AhR wt cells transiently transfected with reporter gene. BaA and BaP, at 10 lM concentration that was found to induce a maximum activity of AhR in human cell-based reporter assay (Vondr a cek et al., 2017), did not inhibit the E2-induced reporter gene activity ( Figure 4B ). We then used MCF-7 AhR KO cells, in order to measure effects of PAHs on activation of ER-dependent luciferase reporter, when their metabolism was compromised. As shown in Figure 4C (right), loss of the AhR-dependent CYP1 activity largely prevented activation of ER-dependent reporter vector in MCF-7 cells by BaA, BaP, or 3MC. We also observed only a low induction of luciferase activity in MCF-7 AhR wt cells after shorter 6 h incubation ( Figure 4B ), suggesting that lower levels of metabolites observed after shorter exposure (Figure 2A ) may not be sufficient to elicit major estrogen-like response in MCF-7 cells.
3-OH-BaP, a Major BaP Metabolite Formed in MCF-7 Cells, Exhibits ER-Dependent Effects on Activation of ER-Dependent Reporter Gene and Cell Cycle Progression in MCF-7 AhR KO Cells
The results of LC-MS/MS analyses indicated that 3-OH-BaP was the most abundant hydroxylated BaP metabolite formed in MCF-7 AhR wt cells. Both 3-OH-BaP and less abundant BaP metabolite, 9-OH-BaP, have been shown to be active in reporter gene and/or E-screen assays in MCF-7 cells (Charles et al., 2000; Fertuck et al., 2001b; van Lipzig et al., 2005) . We observed that 3-OH-BaP and 9-OH-BaP were indeed more potent inducers of ERdependent reporter gene activity in stably transfected T47D.Luc cells than PAHs, including BaA, BaP, or 3MC (Supplementary Figure 4) . As shown in Figure 4C (left), 3-OH-BaP stimulated the activity of ER-dependent reporter gene in a dose-dependent manner in MCF-7 AhR wt cells. Importantly, unlike parent PAHs, 3-OH-BaP also increased luciferase activity in a similar manner to E2 in MCF-7 AhR KO cells ( Figure 4C ; right). Therefore, we hypothesized that this most abundant BaP metabolite identified in MCF-7 cells might play a role in stimulation of cell proliferation. 3-OH-BaP was found to induce cell cycle progression in both MCF-7 AhR wt and MCF-7 AhR KO cells ( Figure 5A ), and the 3-OHBaP-induced transition of cells into S-phase of cell cycle was prevented by synthetic anti-estrogen ICI182,780 ( Figure 5A ), thus confirming that it was ER dependent. 3-OH-BaP was also found to stimulate proliferation of MCF-7 AhR KO cells, albeit to a lower extent than in parent MCF-7 AhR wt cells ( Figure 5B ). This might be attributed to its partial toxicity observed at higher doses. In addition, similar to 3-OH-BaP, the less abundant 9-OHBaP was found to stimulate cell proliferation in MCF-7 AhR KO cells (data not shown). Finally, we compared the effects of E2, BaP, and 3-OH-BaP on levels of two markers associated with progression of cells into S-phase: accumulation of cyclin A2 and phosphorylation of retinoblastoma protein (pRb) (Boylan et al., 1999) in MCF-7 AhR KO cells. As shown in Figure 5C , both E2 and 3-OH-BaP increased levels of cyclin A2 and phospho-pRb (Ser807/811), while BaP (at concentrations up to 25 lM) did not. Together, these results again suggested that metabolites of some PAHs may contribute significantly to their proliferative effects. mental medium for 24 h and then transiently transfected with 3X ERE TATA luc reporter construct and pRL-TK vector, encoding Renilla luciferase (transfection efficiency control). After 24 h of transfection, cells were exposed to DMSO (0.1%; negative control), E2 (100 pM; positive control), or indicated concentrations of PAHs for 24 h. Following the incubation, cells were collected, lysed and firefly/Renilla luciferase activities were determined with a luminometer. The results were expressed relative to maximum luciferase activity induced by reference compound (E2). B, MCF-7 AhR wt cells were grown in experimental medium for 24 h and then transfected with 3X ERE TATA luc reporter construct and pRL-TK vector as above. Aftere 24 h of transfection, cells were exposed to DMSO (0.1%; negative control), E2 (100 pM; positive control), BaA and BaP, or combinations of E2 and the respective PAH, for 6 h. Following the incubation, cells were collected, lysed, and firefly/Renilla luciferase activities were determined with a luminometer. C, MCF-7 AhR wt cells and MCF-7 AhR KO cells were grown in experimental medium for 24 h and then transfected with 3X ERE TATA luc reporter construct and pRL-TK vector as above. After 24 h of transfection, MCF-7 AhR wt cells (left panel) were exposed to DMSO (0.1%; negative control), E2 (100 pM; positive control), or indicated concentrations of 3-OH-BaP for 24 h. MCF-7 AhR KO cells (right panel) were exposed to DMSO, E2 or indicated concentrations of BaA, BaP, 3-OH-BaP, and 3MC for 24 h.
Transfection of MCF-7 AhR
Following the incubation, cells were collected, lysed, and firefly/Renilla luciferase activities were determined with a luminometer. All results were expressed relative to maximum luciferase activity induced by reference compound (E2). The results shown here represent means 6 SD of three independent experiments. Symbol "*" denotes significant difference (p < .05), as compared with DMSO-treated cells. Symbol "**" denotes significant difference (p < .01), as compared with DMSO-treated cells. A, MCF-7 AhR wt and MCF-7 AhR KO cells were synchronized in experimental medium (phenol red-free DMEM/F12, supplemented with 5% dextran/charcoal-treated FBS) for 48 h and then exposed to DMSO (0.1%; negative control) or indicated concentrations of 3-OH-BaP, alone, or in combination with synthetic ER antagonist, ICI 182,780 (ICI; 500 pM), for 24 h. Percentage of cells in S-phase was determined using flow cytometry as described in Materials and Methods. The results represent means 6 SD of three independent experiments. Symbol "*" denotes significant difference (p < .05), as compared with DMSO-treated cells. Symbol "**" denotes significant difference (p < .01), as compared with DMSO-treated cells. Symbol "#" denotes significant difference (p < .05) between the respective 3-OH-BaP treatment group and its combination with ICI. Symbol "##" denotes significant difference (p < .01) between the respective 3-OH-BaP treatment group and its combination with ICI. B, MCF-7 AhR wt and MCF-7 AhR KO cells were synchronized in experimental medium for 48 h and then exposed to DMSO (0.1%; negative control), E2 (100 pM; positive control), or indicated concentrations of 3-OH-BaP for 120 h. Cell proliferation was estimated using WST-1 assay as described in Materials and Methods. The results of absorbance detection were expressed relative to negative control (DMSO) and they represent means 6 SD of three independent experiments. Symbol "*" denotes significant Zhang et al., 2016) . At the same time, many PAHs are also efficient AhR agonists, which control their own metabolism through AhR-dependent transcriptional regulation of CYP1 family enzymes (Nebert and Dalton, 2006) . The activation of the AhR may then lead to formation of known estrogenic metabolites of PAHs (Charles et al., 2000; Fertuck et al., 2001b; Gozgit et al., 2004; van Lipzig et al., 2005) , and it may elicit the inhibitory AhR-ERa cross-talk (Safe and Wormke, 2003) . Some PAHs, such as 3MC, have been also found to activate ERa directly . Loss of the AhR leads to dysregulation of ERa signaling in both male and female mice (Huang et al., 2016) , and the complex interactions of AhR and ER may contribute to adverse effects of contaminants in sensitive tissues, such as breast or lung epithelium (Helle et al., 2016; Kuo et al., 2013; Rodgers et al., 2018) . Both parent PAHs and their hydroxylated metabolites have also been shown to elicit developmental or endocrine-disrupting effects in vivo Booc et al., 2014; Diamante et al., 2017; Kummer et al., 2008; Zhang et al., 2016) . It is thus important to better understand the mechanisms underlying the effects of PAHs on endocrine signaling at the cellular level, as many of the above studies often provide contradictory information about effects of PAHs on estrogen-dependent end-points (Zhang et al., 2016) . Therefore, given the highly complex nature of interactions between AhR and ERa, we examined the impact of PAHs on ERa signaling in the absence of the AhR-regulated metabolism of PAHs. Using the MCF-7 AhR KO cell line as a model, we found that these cells exhibit a near complete loss of both basal and inducible expression/activity of principle enzymes involved in metabolization of PAHs -CYP1A1 and CYP1B1. We used BaP as a model compound, since it has the best defined metabolism among PAHs with known estrogen-like effects (Xue and Warshawsky, 2005) . We found that MCF-7 AhR KO cells do not upregulate either CYP1 enzyme in response to BaP, and that they have only a very limited capacity to produce BaP metabolites, which was particularly relevant for hydroxylated metabolites of BaP, previously shown to activate ERa (Charles et al., 2000; Fertuck et al., 2001b; Gozgit et al., 2004; van Lipzig et al., 2005) . The levels of 3-OH-BaP, a principal metabolite of BaP in MCF-7 AhR wt cells, were reduced by almost three orders of magnitude in MCF-7 AhR KO cells, and a similar trend was observed also for other hydroxylated BaP metabolites. This corresponded with the observed disruption of CYP1 expression/ activity in MCF-7 AhR KO cell line. Importantly, MCF-7 AhR KO cell line remained responsive to endogenous estrogens, such as E2, which both induced ER-dependent luciferase reporter gene and stimulated cell cycle progression/cell proliferation in AhR knockout cells. In addition, neither ERa levels nor induction of its binding to the regulatory regions of genes controlled by ERa (TFF1, GREB1) are affected by the absence of the AhR in this cell line (Ahmed et al., 2014) . This allowed us to examine the proliferative effects of PAHs in this cell model. Cell proliferation or cell cycle progression is a well-defined end-point reflecting ERa activation in human estrogen-sensitive epithelial cell models (Miller et al., 2016; Vanparys et al., 2006 (Charles et al., 2000; Fertuck et al., 2001b; Lam et al., 2017; van Lipzig et al., 2005) . Several hydroxylated metabolites of PAHs, including 2-, 3-, 8-, and 9-OH-BaP have been previously shown to stimulate cell proliferation or induction of ER-dependent reporter genes (Charles et al., 2000; van Lipzig et al., 2005) . All four metabolites have been previously shown to have EC50 values lower than BaP in ER-CALUX assay or in MCF-7 cells (Charles et al., 2000; van Lipzig et al., 2005) . This corresponded well with our own estimation of estrogenic EC50 values of 3-OH-BaP and 9-OH-BaP, which were within nanomolar range as compared with micromolar concentrations of parent PAHs, which were required to produce the same effect. Our LC-MS/MS analyses revealed that 3-OH-BaP was the principle hydroxylated BaP metabolite formed in MCF-7 cells. Therefore, we examined its ability to stimulate activation of ER-dependent reporter gene, cell cycle progression, or cell proliferation in both MCF-7 AhR wt and MCF-7 AhR KO cells. We found that all three end-points were inducible by 3-OH-BaP, and that stimulation of cell cycle progression was fully repressed by synthetic estrogen ICI182,780, thus confirming that the proliferative effects of 3-OH-BaP were ER dependent. The effects on cell proliferation were also confirmed for another hydroxylated BaP metabolite, 9-OH-BaP (data not shown), which was nevertheless formed in significantly lower quantities in MCF-7 cells. 3-OH-BaP, but not BaP, was found to increase cyclin A2 protein levels and pRb phosphorylation in MCF-7 AhR KO cells, two markers associated with progression of cells into S-phase (Boylan et al., 1999) . Together, this seems to imply that 3-OH-BaP was the principle estrogenic metabolite of BaP formed in MCF-7 cells, which mediated the estrogen-like action of its parent compound, BaP. Finally, we attempted to partially restore the BaP metabolism in MCF-7 AhR KO cells through transient transfection with hCYP1A1 and hCYP1B1 enzymes. Transfection with CYP1 enzymes stimulated BaP metabolism and it partly restored formation of 3-OH-BaP as the most abundant BaP metabolite. This was associated with a significant increase in percentage of cells entering S-phase (although lower than in case of E2). This again supports the hypothesis that metabolism of PAHs yields active hydroxylated metabolites, which in turn activate ERa, leading to the induction of ER-dependent cell proliferation in estrogen sensitive cells.
Activation of the AhR leading to repression of estrogenregulated transcription has been shown to be an important toxic mode of action of persistent dioxin-like compounds, which might be independent of its transcriptional partner ARNT (Labrecque et al., 2012; Matthews and Gustafsson, 2006; Safe and Wormke, 2003) . However, both our present data and the previous studies summarized above indicate that the nature of interactions between the AhR and ERa could be more complex in case of readily metabolized AhR ligands, such as PAHs, which produce large quantities of estrogenic metabolites. The AhR-dependent metabolism of PAHs may significantly contribute to their impact on cell proliferation within estrogensensitive cells or tissues. In this context, it is perhaps interesting that estrogenic PAH metabolites can also be formed by human microbiota (Van de Wiele et al., 2004) , hydroxylated PAHs are found in cigarette smoke (Kamiya et al., 2005) or that abundant alkylated PAHs may also form active estrogenic metabolites (Lam et al., 2018) . Polar compounds, including hydroxylated forms of polyaromatic compounds, could be also important contributors to estrogenicity of complex environmental mixtures (Lü bcke-von Varel et al., 2011) . The present study thus contributes to a better understanding of mechanisms underlying the potential endocrine-disrupting activity of environmental PAHs and hydroxylated PAHs linked with ER activation.
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